期刊文献+

Th17/CD4^+ CD25^+ Treg细胞失衡与儿童急性再生障碍性贫血免疫发病机制的关系 被引量:2

下载PDF
导出
摘要 我国是儿童急性再生障碍性贫血(aplastic anemia,AA)的高发国家。然而急性AA的发病机制尚不明确,治疗措施针对性不强,导致其治疗效果不佳,病死率极高。Th17细胞及其分泌的细胞因子介导炎症反应,能诱导严重自身免疫性疾病;
出处 《中国小儿血液与肿瘤杂志》 CAS 2011年第1期38-41,共4页 Journal of China Pediatric Blood and Cancer
  • 相关文献

参考文献21

  • 1Solomou EE, Rezvani K, Mielke S, et al. Deficient CD4 + CD25 + FOXP3 + T regulatory cells in acquired aplastie anemia. Blood, 2007,110 : 1603-1606.
  • 2Yan Gu, Xiaojing Hu, Chuanfang Liu, et al. Interleukin (IL)-17 promotes macrophages to produce IL-8, IL-6 and tumour necrosis factor-a in aplastic anaemia. Br J Haematol, 2008, 142 : 109-114.
  • 3Wahl SM. Transforming growth factor-beta: innately bipolar. Curt Opin Immunol, 2007, 19:55-62.
  • 4Kom T, Bettelli E, Gao W, et al. IL-21 initiates an alternative pathway to induce proinflammatory TH17 cells. Nature, 2007,448: 484-488.
  • 5Huber M, Brustle A, Reinhard K, et al. IRF4 is essential for IL-21- mediated induction, amplification, and stabilization of the Thl7 phenotype. Proc Natl Acad Sci USA, 2008, 105:20546-20851.
  • 6Laurence A, Tato CM, Davidson TS, et al. lnterleukin-2 Signaling via STAT5 Constrains T Helper 17 Cell Generation. Immunity, 2007, 26: 371-381.
  • 7Fitzgerald DC, Ciric B, Touil T, et al. Suppressive Effect of IL-27 on Encephalitogenic Th17 Ceils and the Effector Phase of Experimental Autoirranune Encephalomyelitis. J Immunol, 2007, 179: 3268-3275.
  • 8Kleinschek MA, Owyang AM, Joyce-Shaikh B, et al. IL-25 regulates 33317 function in autoimmune inflammation. JEM, 2007, 204: 161-170.
  • 9Ivanov II, McKenzie BS, Zhou L, et al. The orphan nuclear receptor RORgt directs the differentiation program of proinflammatory IL-17 + T helper cells. Cell, 2006, 126: 1121-1133.
  • 10Annunziato F, Cosmi L, Liotta F,et al. The phenotype of human Th17 cells and their precursors, the cytokines that mediate their differentiation and the role of Th17 cells in inflammation. Int Immunol, 2008, 20 : 1361-1368.

同被引文献21

  • 1黄绍良,黄永兰.儿童特发性再生障碍性贫血的诊断与治疗[J].中国当代儿科杂志,2009,11(2):81-87. 被引量:4
  • 2Young NS, Bacigalupo A, Marsh JC. Aplastic anemia:Pathophysiology and treatment[ J]. Biol Blood Marrow Transplant,2010,16 (1 suppl) : 119 - 125.
  • 3Chang MH, Kim KH, Kim HS,et al. Predictors of response to immuno- suppressive therapy with antithymocyte globulin and cyclosporine and prognostic factors for survival in patients with severe aplastic anemia [J]. Eur J Haematol,2010,84(2) :154 - 159.
  • 4Scheinberg P, Colin OW, Nunez O,et al. Treatment of severe aplastic a- nemia with a combination of horse antithymocyte globulin and eyelospo- fine, with or without sirolimus: A prospective randomized study [ J ]. Haematologica,2009, 94 ( 3 ) : 348 - 354.
  • 5Sakaguchi S,Miyara M,Costantino CM,et al.FOXP3+ regulatory T cells in the human immune system[J].Nat Rev Immunol,2010,10:490-500.
  • 6Afzali B,Lombardi G,Lechler RI,et al.The role ofT helper 17 (Th17) and regulatory T cells (Treg) in human organ transplantation and autoimmune disease[J].Clin Exp Immunol,2007,48:32-46.
  • 7de Latour RP,Visconte V,Takaku T,et al.Th17 immune responses contribute to the pathophysiology of aplastic anemia[J].Blood,2010,116:4175-4184.
  • 8Shi J,Ge M,Lu S,et al.Intrinsic impairment of CD4(+)CD25 (+) regulatory T cells in acquired aplastic anemia[J].Blood,2012,120:1624-1632.
  • 9Young NS.Current concepts in the pathophysiology and treatment of aplastic anemia[J].Hematology Am Soc Hematol Educ Program,2013:76-81.
  • 10Passweg JR,Aljurf M.Treatment and hematopoietic SCT in aplastic anemia[J].Bone Marrow Transplant,2013,48:161.

引证文献2

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部